US Veterans' Health Bill Proposed

24 July 1994

All 27 million American veterans would be eligible for treatment under a revamped health care system approved by the Senate Veterans Affairs Committee, now being taken up by the House Veterans Affairs Committee.

The bill would put the Department of Veterans Affairs, which runs the world's largest health care program, on a competitive basis with other care providers in the new national health care system that the administration hopes to enact. The bill would provide free comprehensive health care benefits for Persian Gulf veterans suffering from undiagnosed illnesses, veterans exposed to radiation and Vietnam veterans exposed to Agent Orange.

Senate Committee chairman John D Rockefeller IV said that under the legislation the VA can finally evolve from an antiquated system to one that offers a comprehensive health care program. The VA's 171 hospitals and 108 outpatient clinics provide care for fewer than 10% of veterans, 2.3 million annually, mostly indigent and those with service-connnected medical problems.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight